Capítulo 3: Ginecología1 Carr A (2001). Integrated medicine. BMJ 322:1484 http://bmj.bmjjournals.com/cgi/content/full/322/7300/1484 2 Dennerstein L (1983). Psychosis and the menstrual cycle. Med J Aust 1(11):524–6. PubMed ID: 6682476 http://www.ncbi.nlm.nih.gov/pubmed/6682476 3 Jones KP (1988). Emotional aspects of endometriosis: a physician’s perspective. Clin Obstet Gynecol 31(4):874–82. PubMed ID: 3229043 http://www.ncbi.nlm.nih.gov/pubmed/3229043 4 Lewis G (ed) (2007). Saving Mothers Lives: Reviewing maternal deaths to make motherhood safer 2003–5. London: CEMACH http://www.publichealth.hscni.net/sites/default/files/Saving%20Mothers’%20Lives%202003-05%20.pdf 5 Teilmann G et al. (2006). Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics118(2):e391–e399 http://pediatrics.aappublications.org/content/118/2/e391 6 James RM, Guideline Development Group (2008). Management of cervical cancer: summary of SIGN guidelines. BMJ336:41. PubMed ID: 18174599 http://www.ncbi.nlm.nih.gov/pubmed/18174599 7 NICE (2004). Fertility: assessment and treatment for people with fertility problems (Clinical Guideline 11) https://www.nice.org.uk/guidance/cg11 8 Xia E et al. (2006). The occurrence and outcome of 39 pregnancies after 1621 cases of transcervical resection of endometrium. Hum Reprod 21(12):3282–6. PubMed ID: 17041231 http://pubmedhh.nlm.nih.gov/cgi-bin/V2cqsr.cgi 9 Cronje WH, et al. (2004). Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod19:2152–5. PubMed ID: 15229203 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=15229203&from=cqsr 10 Rapkin AJ et al. (1997). Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol90:709–14. PubMed ID: 9351749 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=9351749&from=cqsr 11 Berga SL. Understanding premenstrual syndrome. Lancet 351:465. PubMed ID: 9482435 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=9482435&from=cqsr 12 <TBC> http://www.rcog.org.uk/guidelines.asp?PageID=105 13 RCOG (2011). The care of women requesting induced abortion (Evidence-based clinical guideline No. 7) http://www.rcog.org.uk/files/rcog-corp/Abortion%20guideline_web_1.pdf 14 RCOG (2001). Further issues relating to late abortion, fetal viability and registration of births and deathshttp:/www.rcog.org.uk/guidelines.asp?PageID=768 15 RCOG (2010). Understanding how risk is discussd in healthcare (Patient information) http://www.rcog.org.uk/understanding-how-risk-is-discussed-healthcare 16 RCOG (2011). Cervical cerclage (Green-top Guideline No. 60) http://www.rcog.org.uk/womens-health/clinical-guidance/cervical-cerclage-green-top-60 17 RCOG (2006). The management of early pregnancy loss (Green-top Guideline No. 25) https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg25/ 18 RCOG (2005). Disposal following pregnancy loss before 24 weeks’ gestation (Good Practice No. 5) http://www.rcog.org.uk/index.asp?PageID=490 19 Hollett-Caines J et al. (2006). Fertility and pregnancy outcomes following hysteroscopic septum division. J Obstet Gynaecol Can 28:156–9. PubMed ID: 16643719 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=16643719&from=cqsr 20 Noble LS (2005). Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83:684–90. PubMed ID: 15749498 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=15749498&from=cqsr 21 Rai R et al. (1997). Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314(7076):253–7. PubMed ID: 9022487 http://bmj.bmjjournals.com/cgi/content/full/314/7076/253 22 RCOG (2011). Recurrent Miscarriage, Investigation and Treatment of Couples (Green-top Guideline No. 17) https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg17/ 23 RCOG (2011). The management of tubal pregnancy (Green-top Guideline No. 21) https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg21/ 24 Fisher RA et al. (2011). What a difference an egg makes. Lancet 378:1974 http://www.ncbi.nlm.nih.gov/pubmed/22130487 25 Seckl MJ et al. (2010). Gestational trophoblastic disease. Lancet 376:717 http://www.ncbi.nlm.nih.gov/pubmed/20673583 26 RCOG (2003). Lower Genital Tract Neoplasia (Follow up to the 44th RCOG Study Group). London: RCOG 27 RCOG (2011). The management of vulval skin disorders (Green-top Guideline No. 58) https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_58.pdf 28 Luesley DM et al. (2006). Management of vulval cancer. London: RCOG. 29 NICE (2009). Balloon catheter insertion for Bartholin’s cyst or abscess (IPG 323) http://www.nice.org.uk/guidance/ipg323 30 RCOG (2002). Fetal and maternal risks of diethylstilboestrol exposure in pregnancy (RCOG Statement No. 2) http://aogm.org.mo/assets/Uploads/aogm/Guidelines/RCOG---UK/RCOGStatementNo2.pdf 31 Tomlinson IP et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Multiple Leiomyoma Consortium. Nat Genet 30:406–10. PubMed ID: 11865300 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=11865300&from=cqsr 32 Spencer CP (1999). Endometrial assessment re-visited. Br J Obstet Gynaecol 106(7):623–32. http://www.ncbi.nlm.nih.gov/m/pubmed/10428515/ 33 NICE (2011). The recognition and initial management of ovarian cancer (Clinical Guideline 122) http://www.nice.org.uk/guidance/cg122 34 Morris M et al. (2001). Bacterial vaginosis: a public health review. BJOG 108(5):439–50. PubMed ID: 11368127 http://pubmedhh.nlm.nih.gov/cgi-bin/V2cqsr.cgi 35 NICE (2007). Mesh sacrocolpopexy for vaginal vault prolapse (IPG 215) http://guidance.nice.org.uk/ipg215 36 Milton J. Paradise Lost. (Book VIII, starting at line 465) http://books.google.com/books?id=2Ai9jChyvWUC&pg=PA179&lpg=PA179&dq=and+lifeblood+streaming+fresh&source=web&ots=1Ac9m_GE1F&sig=Gmx0WFOB6Tu_3-RbZ7d6Rqd24M4&hl=en&sa=X&oi=book_result&resnum=4&ct=result 37 Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit (2007). Female barrier methods. <TBC> 38 NICE (2012). Clinical Knowledge Summaries: Contraception http://cks.nice.org.uk/contraception-assessment#!background 39 Stanback J (1999). Checklist for ruling out pregnancy among family-planning clients in primary care. Lancet 354(9178):566 http://www.ncbi.nlm.nih.gov/pubmed/10470704 40 Faculty of Sexual and Reproductive Healthcare (2011, updated 2012). Emergency contraceptionhttp://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf 41 Webb AM (2004). Emergency contraception: latest changes. J Fam Plann Reprod Health Care 30(1):7–9. PubMed ID: 15006303 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=15006303&from=cqsr 42 Faculty of Sexual and Reproductive Healthcare (2009). UK medical eligibility criteria for contraceptive use 2009http://www.fsrh.org/pdfs/UKMEC2009.pdf 43 MacGregor EA et al. (1998). Combined oral contraceptives, migraine and ischaemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Br J Fam Plann 24(2):55–60. PubMed ID: 9719712 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=9719712&from=cqsr 44 Mansour D (2005). Missed contraceptive pills and the critical pill-free interval. Lancet 365:1670–1 http://www.ncbi.nlm.nih.gov/pubmed/15894085 45 RCOG (2010). Venous thromboembolism and hormonal contraception (Green-top guidance 40) http://www.rcog.org.uk/womens-health/clinical-guidance/venous-thromboembolism-and-hormonal-contraception-green-top-40 46 Dinger J (2007). The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 75:344–54. Pubmed 17434015 http://www.ncbi.nlm.nih.gov/pubmed/17434015 47 RCOG (2006). FFPRHC Guidance: Emergency contraception http://www.fsrh.org/pages/Clinical_Guidance_2.asp 48 NICE (2009). Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants (IPG 315) https://www.nice.org.uk/guidance/ipg315 49 Cook L et al. (2007). Vasectomy occlusion techniques for male sterilization. Cochrane Database Syst Rev 2:CD003991. PubMed ID: 17443535. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=17443535&from=cqsr 50 Cook LA et al. (2007). Scalpel versus no-scalpel incision for vasectomy. Cochrane Database Syst Rev 2:CD004112. PubMed ID: 17443540 http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=17443540&from=cqsr 51 RCOG (2011). Best practice in outpatient hysteroscopy (Green-top Guideline No. 59) https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg59/ 52 RCOG (2005). The initial management of chronic pelvic pain (Green-top Guideline No. 41) http://www.rcog.org.uk/index.asp?PageID=1124 |